2016

Cresswell GD, Apps JR, Chagtai T, Mifsud B, Bentley CC, Maschietto M, Popov SD, Weeks ME, Olsen ØE, Sebire NJ, Pritchard-Jones K, Luscombe NM, Williams RD, Mifsud W
Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications
EBioMedicine. 2016 Jul;9:120-129. doi: 10.1016/j.ebiom.2016.05.029 -> Abstract PubMed

Brok J, Treger TD, Gooskens SL, van den Heuvel-Eibrink MM, Pritchard-Jones K
Biology and treatment of renal tumours in childhood
Eur J Cancer. 2016 Oct 28;68:179-195. doi: 10.1016/j.ejca.2016.09.005 -> Abstract PubMed

Arora RS, Challinor JM, Howard SC, Israels T
Improving Care for Children With Cancer in Low- and Middle-Income Countries--a SIOP PODC Initiative
Pediatr Blood Cancer. 2016 Mar;63(3):387-91. doi: 10.1002/pbc.25810 -> Abstract PubMed

Scalabre A, Bergeron C, Brioude F, Dainese L, Cropet C, Coulomb L'hermine A, Pasqualini C, Auber F, Verschuur A, Schleiermacher G, Le Bouc Y, Audry G, Irtan S
Is Nephron Sparing Surgery Justified in Wilms Tumor With Beckwith-Wiedemann Syndrome or Isolated Hemihypertrophy?
Pediatr Blood Cancer. 2016 Sep;63(9):1571-7. doi: 10.1002/pbc.26073 -> Abstract PubMed

Irtan S, Erlich PF, Pritchard-Jones K
Wilms tumor: "State-of-the-art" update, 2016
Semin Pediatr Surg. 2016 Oct;25(5):250-256. doi: 10.1053/j.sempedsurg.2016.09.003 -> Abstract PubMed

Ooms AH, Gadd S, Gerhard DS, Smith MA, Guidry Auvil JM, Meerzaman D, Chen QR, Hsu CH, Yan C, Nguyen C, Hu Y, Ma Y, Zong Z, Mungall AJ, Moore RA, Marra MA, Huff V, Dome JS, Chi YY, Tian J, Geller JI, Mullighan CG, Ma J, Wheeler DA, Hampton OA, Walz AL, van den Heuvel-Eibrink MM, de Krijger RR, Ross N, Gastier-Foster JM, Perlman EJ
Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group
Clin Cancer Res. 2016 Nov 15;22(22):5582-5591. doi: 10.1158/1078-0432.CCR-16-0985 -> Abstract PubMed

Powis M
Quality-assured cancer surgery for Wilms tumour: What is the role of the clinical trials groups?
Pediatr Blood Cancer. 2016 Nov;63(11):1882-3. doi: 10.1002/pbc.26151 -> Abstract PubMed

Charlton J, Pritchard-Jones K
WT1 Mutation in Childhood Cancer
Methods Mol Biol. 2016;1467:1-14. doi: 10.1007/978-1-4939-4023-3_1 -> Abstract PubMed

Spreafico F, Ciceri S, Gamba B, Torri F, Terenziani M, Collini P, Macciardi F, Radice P, Perotti D
Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences
Oncotarget. 2016 Feb 23;7(8):8908-15. doi: 10.18632/oncotarget.6950 -> Abstract PubMed

Eggert A, Simon T, von Schweinitz D, Timmermann B, Graf N
Embryonale Bauchtumoren im Kindes- und Jugendalter
Onkologe (2016) 22: 940. doi:10.1007/s00761-016-0136-z -> Download

Chagtai T, Zill C, Dainese L, Wegert J, Savola S, Popov S, Mifsud W, Vujani? G, Sebire N, Le Bouc Y, Ambros PF, Kager L, O'Sullivan MJ, Blaise A, Bergeron C, Mengelbier LH, Gisselsson D, Kool M, Tytgat GA, van den Heuvel-Eibrink MM, Graf N, van Tinteren H, Coulomb A, Gessler M, Williams RD, Pritchard-Jones K
Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study
J Clin Oncol. 2016 Sep 10;34(26):3195-203. doi: 10.1200/JCO.2015.66.0001 -> Abstract PubMed

Apelt N, Hubertus J, Mayr D, Graf N, Furtwängler R, Von Schweinitz D, Kappler R
Association of FOXM1 expression with tumor histology and prognosis in Wilms tumor: Potential for a new prognostic marker
Oncology Letters 12.4 (2016): 2854-2859 -> Download